Wallace pharma presentation
-
Upload
wallacepharma -
Category
Health & Medicine
-
view
485 -
download
10
Transcript of Wallace pharma presentation
![Page 1: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/1.jpg)
![Page 2: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/2.jpg)
Manufacturers and exporters of Quality & Generic Pharmaceuticals
![Page 3: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/3.jpg)
Range of productsInjectablesIntravenous solutionsTabletsCapsulesSuspensionsOral Rehydration saltsSpeciality Products
![Page 4: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/4.jpg)
Injectables Prednisolone Sodium
Phosphate Injection USP 50mg/10 ml
Therapeutic Class: Corticosteroid Hormone
Indications:o Allergic and inflammatory disorderso Poorly controlled, moderate to severe
asthmao Nephrotic syndromeo Rheumatoid arthritis
![Page 5: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/5.jpg)
Aminophylline Injection BP 240 mg/10 ml
Therapeutic Class: Antiasthmatic & COPD preparations.
Indications: Treatment of pulmonary oedema
treatment of obstructive airway diseases.
Injectables
![Page 6: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/6.jpg)
InjectablesKanamycin Injection USP 2 gm
Therapeutic Class: Aminoglycoside
Indications: o Intravenous: Susceptible Gram-negative and
staphylococcal infectionso Penicillin-resistant gonorrhoeao Intramuscular:
Treatment and prophylaxis of neonatal gonococcal infections
![Page 7: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/7.jpg)
InjectablesMAXERON Metoclopramide Injection BP 10 mg/2 ml
Therapeutic Class: GIT Regulators, Antiflatulents & Anti-Inflammatories / Antiemetics
Indications:Nausea and vomiting , relieves the symptoms of gastro-duodenal dysfunction including:Dyspepsia,Heartburn,Flatulence,Sickness,Regurgitation of bile,Pain
![Page 8: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/8.jpg)
InjectablesAQUIVIT
Vitamin B-complex Injection Therapeutic Class: Vitamin B Complex supplement
Indications: o Dietary supplements, o Deficiency of B complex Vitamins
![Page 9: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/9.jpg)
InjectablesGentamicin Injection BP
80 mg/2 ml Therapeutic Class: Aminoglycoside (Broad spectrum)
Indications: Antibacterialo as a supplement to systemic therapy in bacterial meningitis, ventriculitis and other bacterial infections of
the central nervous system.
![Page 10: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/10.jpg)
InjectablesFurosemide injection BP
20 mg/2 ml Therapeutic Class: Diuretics
Indications: o Oliguria in acute or chronic renal failureo Nephrotic Syndrome
![Page 11: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/11.jpg)
InjectablesCeftriaxone Sodium For Injection USP 1.0
g Therapeutic Class: Cephalosporin Antibiotic (Bactericidal)
Indications: o In the treatment of the following infectionso Pneumoniao Septicaemiao Meningitiso Skin and soft tissue infectionso Infections in neutropenic patientso Gonorrhoeao Peri-operative prophylaxis of infections associated with surgery
![Page 12: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/12.jpg)
Ampicillin Sodium For Injection 500 mg Therapeutic Class: Penicillin with extended spectrum.
Indications: o Systemic infectionso Respiratory Tract Infectionso Bacterial Meningitis o Septicemia and Endocarditiso Urinary Tract Infectionso Gastrointestinal Infections
Injectables
![Page 13: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/13.jpg)
Intravenous (I.V.) Solutions
Paracetamol infusion 1.0% w/v
Therapeutic Class: Analgesics (Non-Opioid) & Antipyretics
Indications: Used to relieve mild to moderate pain and fever.
![Page 14: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/14.jpg)
Metronidazole Injection USP 500 mg/100 ml
Therapeutic Class: Imidazole Derivative , Antiamoebic
Indications: o Anaerobic bacterial infectionso Prophylaxis of postoperative anaerobic
bacterial infectionso Hepatic Impairment
Intravenous (I.V.) Solutions
![Page 15: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/15.jpg)
Ciprofloxacin Injection BP 200 mg/100 ml
Therapeutic Class: Quinolone derivative, Anti-infective Indications:
o Susceptible infections o Q fever o Spotted fever o Typhuso Urinary tract infectionso Bone and joint infections o Infections in immunocompromised patients
Intravenous (I.V.) Solutions
![Page 16: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/16.jpg)
TabletsTiniwal 500
Tinidazole Tablets 500 mg
Therapeutic Class: Antiamoebic
Indications: o Systemic infectionso Treatment of amoebiasis and other
protozoal diseases.
![Page 17: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/17.jpg)
Tramadol Tablets 50 mg
Therapeutic Class: Opioid Analgesic.
Indications: o To relieve moderate to severe pain.o To relieve acute paino To relieve pain associated with
chronic conditions
Tablets
![Page 18: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/18.jpg)
OPARA 500 Paracetamol Tablets 500 mg
Therapeutic Class: Analgesics (Non-Opioid) & Antipyretics.
Indications: Used to relieve mild to moderate pain and
fever.
Tablets
![Page 19: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/19.jpg)
Peniwal VK 250 Phenoxymethylpenicillin Tablets BP 250
mg Therapeutic Class: Penicillins Indications:
o Prophylaxis of recurrent rheumatic fevero Streptococcal infections of the upper respiratory tract,
including scarlet fever and erysipelaso Pneumococcal infections of the respiratory tract,
including otitis mediao Staphylococcal infections of the skin and soft tissueo Susceptible infections
Tablets
![Page 20: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/20.jpg)
Metrowal 250 Metronidazole Tablets BP 250 mg
Therapeutic Class: Imidazole Derivative, Antiamoebic.
Indications: o Anaerobic bacterial infections.o Used in the treatment of amoebiasis and other protozoal
diseases.
Tablets
![Page 21: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/21.jpg)
Vitamin B-complex Tablets Therapeutic Class: Vitamin B Complex
supplement
Indications: o Dietary supplementso Deficiency of B complex Vitamins
Tablets
![Page 22: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/22.jpg)
Multivitamin TabletsMultivitamin Tablets
Therapeutic Class: Vitamins
Indications: Used as dietary supplement
Tablets
![Page 23: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/23.jpg)
Cotriwal 480 Cotrimoxazole Tablets BP 480 mg
Therapeutic Class: Antibacterial Combination (sulfamethoxazole + trimethoprim)
Indications:o Used in the treatment of systemic infectionso GI infections;o Respiratory and Urinary tract infections
Tablets
![Page 24: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/24.jpg)
Walamox 250 & Walamox 500 Amoxicillin Capsules BP
Therapeutic Class: Penicillins (Beta lactum antibiotics)
Indications: Treatment of systemic infections
Capsules
![Page 25: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/25.jpg)
Ampiwal 500 Ampicillin Capsules BP 500
mg
Therapeutic Class: Penicillins (Beta lactum antibiotics)
Indications: Treatment of systemic infections
Capsules
![Page 26: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/26.jpg)
OMEWAL 20 Gastro resistant omeprazole Capsules BP
20 mg Therapeutic Class: Antacid, Antireflux Agent &
Antiulcerant
Indications: Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
Capsules
![Page 27: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/27.jpg)
SuspensionsOPARA
Paracetamol Oral Suspension BP 125mg/5 ml
Therapeutic Class: Analgesics (Non-Opioid) & Antipyretics
Indications: Used to relieve mild to moderate pain and fever.
![Page 28: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/28.jpg)
METROWAL Metronidazole Oral suspension BP 125
mg/5 ml
Therapeutic Class: Imidazole Derivative, Antiamoebic
Indications: o Anaerobic bacterial infectionso Used in the treatment of amoebiasis and other protozoal
diseases.
Suspensions
![Page 29: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/29.jpg)
COTRIWAL Paediatric Co-trimoxazole Oral
Suspension240mg/5ml
Therapeutic Class: Antibacterial Combination (sulfamethoxazole + trimethoprim)
Indications: o Used in the treatment of systemic infectionso GI infectionso Respiratory and Urinary Tract Infections
Suspensions
![Page 30: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/30.jpg)
NYSTAWAL Nystatin Oral suspension BP
Therapeutic Class: Antifungal
Indications: o Intestinal infections o Fungal infections
Suspensions
![Page 31: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/31.jpg)
WALAMOX 250 Amoxicillin Oral suspension BP
250 mg/5 ml Therapeutic Class: Penicillin
Indications: Systemic Infections
Suspensions
![Page 32: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/32.jpg)
Oral rehydration
saltsOral rehydration salts BP 27.9 gm
Therapeutic Class: Electrolytes
Indications: o Treatment of diarrheao Vomiting
Composition: Each 27.9 gm contains:
Sodium Chloride B.P. .... 3.5 gm
Potassium Chloride B.P. 1.5 gm
Sodium Citrate B.P......... 2.9 gm
Glucose Anhydrous B.P. 20.0gm
![Page 33: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/33.jpg)
Speciality Products
Therapeutic Class: ANTIRETROVIRALS
Indications:
Antiretroviral drugs are medications for the treatment of infection by retroviruses, primarily HIV.
![Page 34: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/34.jpg)
Range of anti retrovirals:Zila-
N(Zidovudine+Lamivudine+Nevirapine)
![Page 35: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/35.jpg)
Range of anti retrovirals:Zila (Zidovudine+Lamivudine)
![Page 36: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/36.jpg)
Range of anti retrovirals:TELA-
E(Tenfovir+Lamivudine+Efeviraenz)
![Page 37: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/37.jpg)
Range of anti retrovirals:TELA(Tenfovir+Lamivudine)
![Page 38: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/38.jpg)
Range of anti retrovirals:WALARENZ(Efevirenz)
![Page 39: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/39.jpg)
![Page 40: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/40.jpg)
![Page 41: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/41.jpg)
![Page 42: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/42.jpg)
![Page 43: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/43.jpg)
![Page 44: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/44.jpg)
![Page 45: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/45.jpg)
![Page 46: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/46.jpg)
![Page 47: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/47.jpg)
![Page 48: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/48.jpg)
![Page 49: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/49.jpg)
![Page 50: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/50.jpg)
![Page 51: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/51.jpg)
![Page 52: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/52.jpg)
![Page 53: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/53.jpg)
![Page 54: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/54.jpg)
![Page 55: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/55.jpg)
![Page 56: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/56.jpg)
![Page 57: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/57.jpg)
![Page 58: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/58.jpg)
![Page 59: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/59.jpg)
![Page 60: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/60.jpg)
![Page 61: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/61.jpg)
![Page 62: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/62.jpg)
![Page 63: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/63.jpg)
![Page 64: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/64.jpg)
![Page 65: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/65.jpg)
![Page 66: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/66.jpg)
![Page 67: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/67.jpg)
![Page 68: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/68.jpg)
![Page 69: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/69.jpg)
![Page 70: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/70.jpg)
![Page 71: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/71.jpg)
![Page 72: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/72.jpg)
![Page 73: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/73.jpg)
![Page 74: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/74.jpg)
![Page 75: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/75.jpg)
![Page 76: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/76.jpg)
![Page 77: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/77.jpg)
![Page 78: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/78.jpg)
![Page 79: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/79.jpg)
![Page 80: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/80.jpg)
![Page 81: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/81.jpg)
![Page 82: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/82.jpg)
![Page 83: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/83.jpg)
![Page 84: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/84.jpg)
![Page 85: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/85.jpg)
![Page 86: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/86.jpg)
![Page 87: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/87.jpg)
![Page 88: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/88.jpg)
![Page 89: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/89.jpg)
![Page 90: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/90.jpg)
![Page 91: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/91.jpg)
![Page 92: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/92.jpg)
![Page 93: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/93.jpg)
![Page 94: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/94.jpg)
![Page 95: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/95.jpg)
![Page 96: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/96.jpg)
![Page 97: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/97.jpg)
![Page 98: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/98.jpg)
![Page 99: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/99.jpg)
![Page 100: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/100.jpg)
![Page 101: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/101.jpg)
![Page 102: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/102.jpg)
![Page 103: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/103.jpg)
![Page 104: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/104.jpg)
![Page 105: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/105.jpg)
![Page 106: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/106.jpg)
![Page 107: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/107.jpg)
![Page 108: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/108.jpg)
![Page 109: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/109.jpg)
![Page 110: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/110.jpg)
![Page 111: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/111.jpg)
![Page 112: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/112.jpg)
![Page 113: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/113.jpg)
![Page 114: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/114.jpg)
![Page 115: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/115.jpg)
![Page 116: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/116.jpg)
![Page 117: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/117.jpg)
![Page 118: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/118.jpg)
![Page 119: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/119.jpg)
![Page 120: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/120.jpg)
![Page 121: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/121.jpg)
![Page 122: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/122.jpg)
![Page 123: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/123.jpg)
![Page 124: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/124.jpg)
![Page 125: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/125.jpg)
![Page 126: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/126.jpg)
![Page 127: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/127.jpg)
![Page 128: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/128.jpg)
Wallace Pharmaceuticals Pvt.Ltd.B/307-312,Floral Deck Plaza,
Off.Central M.I.D.C. Road,Andheri East,Mumbai-400 093 (India)
Ph. No.2926 1100Website:www.wallacepharma.net
Email:[email protected]
Contact Persons:
Mr. Ronald Vincent SequeiraGeneral Manager-ExportsMob:9820822134
Mr.Sanjay GawaliSr. Export ManagerMob.+91-7738679725
![Page 129: Wallace pharma presentation](https://reader038.fdocuments.in/reader038/viewer/2022102802/589f85511a28abf0638b62e1/html5/thumbnails/129.jpg)